Microfluidic chip-based technologies: emerging platforms for cancer diagnosis.

Area of Science:

• Biomedical Engineering
• Oncology
• Diagnostics

Background:

• Early and personalized cancer diagnosis is crucial for reducing mortality and improving patient outcomes.
• Traditional diagnostic methods are often time-consuming, costly, and require bulky equipment.
• Microfluidic platforms offer a potential alternative for rapid, precise, and cost-effective cancer screening.

Purpose of the Study:

• To overview the applications of microfluidic technologies in cancer detection and monitoring.
• To highlight the role of microfluidics in personalized cancer diagnosis through biomarker analysis.
• To discuss future prospects of microfluidic systems in tumor screening.

Main Methods:

• Review of current literature on microfluidic applications in cancer diagnostics.
• Analysis of microfluidic platforms for nucleic acid and protein biomarker detection.
• Exploration of microfluidics in cancer cytology for functional diagnosis.

Main Results:

• Microfluidic devices enable high-throughput and high-precision analysis of cancer biomarkers.
• These platforms offer reduced equipment costs and analysis times compared to traditional methods.
• Microfluidics shows potential for personalized cancer diagnosis and improved screening.

Conclusions:

• Microfluidic technologies are a promising tool for advancing early cancer detection and personalized medicine.
• Further development of microfluidic systems can enhance tumor screening and patient management.
• The integration of microfluidics into diagnostic protocols is expected to significantly impact cancer care.